A phase 2 trial of leflunomide, pomalidomide, and dexamethasone for relapsed/refractory multiple myeloma
Clinical Lymphoma Myeloma and Leukemia(2023)
Key words
relapsed/refractory relapsed/refractory multiple myeloma,multiple myeloma,pomalidomide,dexamethasone
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined